18 research outputs found
Effects of the induced magnetic field, thermophoresis, and Brownian motion on mixed convective Jeffrey nanofluid flow through a porous channel
Simultaneous realization of direct photodeposition and high H2-production activity of amorphous cobalt sulfide nanodot-modified rGO/TiO2 photocatalyst
Decoration of mesoporous graphite-like C3N4 nanosheets by NiS nanoparticle-driven visible light for hydrogen evolution
Dynamics of distributed-order hyperchaotic complex van der Pol oscillators and their synchronization and control
Acceptability, growth performance and nutritional status of chickens fed cassava leaf meal (CLM)–based diets
Hydrogen evolution from photocatalytic water splitting by LaMnO3 modified with amorphous CoSx
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
SARS-CoV-2, the virus causing COVID-19, is a single-stranded RNA virus belonging to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae. SARS-CoV-2 entry to cellsis initiated by the binding of the viral spike protein (S) to its cellular receptor. The roles of S protein in receptor binding and membrane fusion makes it a prominent target for vaccine development. SARS-CoV-2 genome sequence analysis has shown that this virus belongs to the beta-coronavirus genus, which includes Bat SARS-like coronavirus, SARS-CoV and MERS-CoV. A vaccine should induce a balanced immune response to elicit protective immunity. In this review, we compare and contrast these three important CoV diseases and how they inform on vaccine development